TriSalus Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TriSalus Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q4 2024.
  • TriSalus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$10.1M, a 71.6% increase year-over-year.
  • TriSalus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$30M, a 49.4% increase year-over-year.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$30M, a 49.4% increase from 2023.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$59.4M, a 25.8% decline from 2022.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$47.2M, a 1090% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 -$10.1M +$25.5M +71.6% Dec 31, 2024 10-K 2025-04-15
Q3 2024 -$2.4M -$974K -68.4% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$4.33M +$9.65M +69% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$13.2M -$4.89M -58.9% Mar 31, 2024 10-K 2025-04-15
Q4 2023 -$35.6M -$13.1M -58.1% Dec 31, 2023 10-K 2025-04-15
Q3 2023 -$1.43M +$6.67M +82.4% Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$14M -$5.31M -61.1% Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$8.31M -$440K -5.59% Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$22.5M -$25.4M -878% Dec 31, 2022 10-K 2024-04-11
Q3 2022 -$8.09M -$9.96M -534% Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$8.68M -$9.06M -2391% Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$7.87M -$7.5M -2016% Mar 31, 2022 10-Q 2023-11-14
Q4 2021 $2.9M +$3.61M Dec 31, 2021 10-K 2023-03-22
Q3 2021 $1.86M +$1.87M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $379K Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$372K Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$711K Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$1K* Sep 30, 2020 10-Q/A 2021-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.